117 related articles for article (PubMed ID: 31532101)
21. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
22. Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer.
Bernal G
Int J Biol Markers; 2012 Jul; 27(2):e82-9. PubMed ID: 22427189
[TBL] [Abstract][Full Text] [Related]
23. Detection and prevention of colon cancer: colonoscopy, virtual colonoscopy, and DNA stool tests.
Lidofsky S
Med Health R I; 2005 Mar; 88(3):82-5. PubMed ID: 15915780
[No Abstract] [Full Text] [Related]
24. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
[TBL] [Abstract][Full Text] [Related]
25. DNA Marker in Stool Led to a Second High-Quality Colonoscopy Within Three Months and Removal of an Undetected High-Risk Polyp.
Franck S; Eidens M; Fuhrländer J; Ogreid D
Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213210
[TBL] [Abstract][Full Text] [Related]
26. Multi-Target Stool DNA Test: Is the Future Here?
Sweetser S; Ahlquist DA
Curr Gastroenterol Rep; 2016 Jun; 18(6):30. PubMed ID: 27165404
[TBL] [Abstract][Full Text] [Related]
27. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
[TBL] [Abstract][Full Text] [Related]
28. [Advances in early diagnosis of colorectal cancer based on detection of RNAs in stool.].
Qi ZT; Deng LL; Huang H; Zhao JH; Zhou GH
Yi Chuan; 2010 Oct; 32(10):994-1002. PubMed ID: 20943486
[TBL] [Abstract][Full Text] [Related]
29. Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer.
Calistri D; Rengucci C; Molinari C; Ricci E; Cavargini E; Scarpi E; Milandri GL; Fabbri C; Ravaioli A; Russo A; Amadori D; Silvestrini R
Cell Oncol; 2009; 31(1):11-7. PubMed ID: 19096146
[TBL] [Abstract][Full Text] [Related]
30. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
31. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer.
Lev Z; Kislitsin D; Rennert G; Lerner A
J Cell Biochem Suppl; 2000; 34():35-9. PubMed ID: 10762013
[TBL] [Abstract][Full Text] [Related]
32. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
Doolittle BR; Emanuel J; Tuttle C; Costa J
Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
[TBL] [Abstract][Full Text] [Related]
33. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
Schroy PC; Heeren TC
Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
[TBL] [Abstract][Full Text] [Related]
34. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
35. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
36. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
[TBL] [Abstract][Full Text] [Related]
37. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.
Haug U; Hillebrand T; Bendzko P; Löw M; Rothenbacher D; Stegmaier C; Brenner H
Clin Chem; 2007 Apr; 53(4):787-90. PubMed ID: 17317884
[TBL] [Abstract][Full Text] [Related]
38. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
Chen H; Werner S; Brenner H
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
[TBL] [Abstract][Full Text] [Related]
39. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
Brand RE; Ross ME; Shuber AP
Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
[TBL] [Abstract][Full Text] [Related]
40. Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of
Galanopoulos M; Papanikolaou IS; Zografos E; Viazis N; Papatheodoridis G; Karamanolis D; Marinos E; Mantzaris GJ; Gazouli M
Anticancer Res; 2017 Feb; 37(2):651-657. PubMed ID: 28179313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
